We Help Companies Find New Sales Opportunities
Wyeth is to acquire Haptogen, the Aberdeen-based biopharmaceutical therapies company with 30 staff, for an estimated £25m.
Wyeth Pharmaceuticals is considering plans to relocate its UK headquarters from Maidenhead to a 100,000 sq ft site at Green Park in Reading.
Wyeth Pharmaceuticals is seeking a suitable site to open a 100,000 sq ft office between Reading and Slough.
Wyeth and Scottish Enterprise are to invest £50m in medical research work in Scotland, including drug development at the universities of Glasgow, Aberdeen, Edinburgh and Dundee, and a central research centre with 50 staff in Dundee.